<div class="module_links module_q4-icon-links">
<div class="module_related-document">
<a href="//s21.q4cdn.com/825405078/files/doc_news/2014/201410_IDE_Supplement.pdf" id="_ctrl0_ctl15_hrefDownload" class="module_link module_news-details_download" target="_blank">
<span id="_ctrl0_ctl15_lblDownload" class="module_link-text">Download this Press Release</span>
<span class="sr-only">PDF Format (opens in new window)</span>
<span id="_ctrl0_ctl15_lblDocument" class="module_file-size">PDF 43 KB</span>
</a>
</div>

</div>
<div class="module_body">

</div>

</div>
</div>
</div>

</div>
</div>

Novocure Announces FDA Approval of an IDE Supplement Allowing All Control Patients in its Phase III Trial in Newly Diagnosed GBM to Cross Over to Receive Tumor Treating Fields